Dimensional Fund Advisors LP Genprex, Inc. Transaction History

Dimensional Fund Advisors LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$1.28 - $2.31 $2,508 - $4,527	1,960 Added 9.48%	22,644 $31,000
Q3 2021 Nov 12, 2021	SELL	$2.59 - $3.36 $56,218 - $72,932	-21,706 Reduced 51.21%	20,684 $55,000
Q2 2021 Aug 12, 2021	BUY	$3.11 - $4.87 $131,832 - $206,439	42,390 New	42,390 $142,000

600

Ticker GNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,300
Market Cap $76.8M
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.